Valiant Organics Ltd
VALIANTORG NSE
Valiant Organics Ltd
CommoditiesNSE: VALIANTORG BSE: 540145 Chemicals & Petrochemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹847 Cr
Volatility
Moderate
P/E Ratio
16.89
EBITDA
₹87.06 Cr
Return on Equity
-0.47%
Debt to Equity
0.31
Book Value
₹270.88
52W High
₹397
52W Low
₹195
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Valiant Organics Ltd insights
53 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
2- The company has delivered a poor sales growth of 5.16% over past five years.
- Company has a low return on equity of 0.97% over last 3 years.
Growth Rate
Revenue Growth
1.56% ↘
Net Income Growth
-1407.65% ↘
Cash Flow Change
-32.82% ↘
ROE
-59.13% ↘
ROCE
248.35% ↗
EBITDA Margin (Avg.)
35.24% ↘
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 177 | 182 | 141 | 177 | 168 | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| Expenses | 156 | 165 | 138 | 179 | 152 | 158 | 172 | 183 | 180 | 136 | 143 | 191 | 190 |
| Operating Profit | 20 | 17 | 4 | -2 | 16 | 2 | 15 | 21 | 25 | 21 | 16 | 26 | 42 |
| OPM % | 11% | 9% | 2.7% | -1% | 9% | 1.5% | 8% | 10% | 12% | 13% | 10% | 12% | 18% |
| Other Income | 6 | 0 | 0 | 2 | 0 | 2 | 5 | 1 | 1 | 0 | 7 | 4 | 3 |
| Interest | 4 | 4 | 4 | 7 | 5 | 8 | 6 | 5 | 6 | 4 | 5 | 3 | 5 |
| Depreciation | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 |
| PBT | 14 | 5 | -9 | -16 | 2 | -13 | 6 | 7 | 10 | 7 | 8 | 17 | 29 |
| Tax % | 25% | 26% | -22% | -32% | 118% | -12% | 16% | 44% | 28% | 24% | 27% | 11% | 25% |
| Net Profit | 10 | 4 | -7 | -11 | 0 | -11 | 5 | 4 | 8 | 6 | 6 | 15 | 22 |
| EPS in Rs | 3.82 | 1.44 | -2.43 | -3.86 | -0.16 | -4.04 | 1.68 | 1.41 | 2.71 | 2 | 2.16 | 5.4 | 7.78 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59 | 52 | 73 | 121 | 606 | 584 | 574 | 948 | 912 | 677 | 719 | 738 | 766 |
| Expenses | 48 | 36 | 55 | 94 | 426 | 410 | 417 | 783 | 782 | 638 | 665 | 650 | 661 |
| Operating Profit | 11 | 16 | 18 | 26 | 179 | 174 | 157 | 165 | 130 | 40 | 54 | 88 | 105 |
| OPM % | 19% | 30% | 25% | 22% | 30% | 30% | 27% | 17% | 14% | 6% | 7% | 12% | 14% |
| Other Income | 1 | 1 | 2 | 1 | 5 | 5 | 17 | 6 | 8 | 9 | 8 | 13 | 14 |
| Interest | 1 | 0 | 0 | 0 | 2 | 1 | 3 | 6 | 11 | 19 | 24 | 18 | 17 |
| Depreciation | 1 | 1 | 2 | 2 | 12 | 13 | 19 | 27 | 28 | 34 | 36 | 40 | 40 |
| PBT | 11 | 16 | 18 | 25 | 171 | 165 | 152 | 137 | 100 | -5 | 2 | 43 | 62 |
| Tax % | 34% | 35% | 35% | 35% | 29% | 25% | 25% | 25% | 24% | -41% | 224% | 20% | — |
| Net Profit | 7 | 10 | 12 | 16 | 121 | 124 | 115 | 103 | 76 | -3 | -3 | 34 | 49 |
| EPS in Rs | 104 | 14.03 | 15.92 | 13.97 | 104 | 51 | 42.2 | 37.91 | 27.83 | -1.1 | -1.07 | 12.26 | 17.34 |
| Div. Payout % | 50% | 71% | 16% | 23% | 6% | 11% | 12% | 9% | 4% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.36 | 4 | 4 | 6 | 6 | 12 | 27 | 27 | 27 | 28 | 28 | 28 |
| Reserves | 21 | 19 | 42 | 53 | 254 | 374 | 475 | 576 | 638 | 637 | 634 | 669 |
| Borrowings | 8 | 1 | 1 | 1 | 53 | 119 | 150 | 306 | 220 | 216 | 212 | 219 |
| Other Liabilities | 11 | 17 | 23 | 36 | 89 | 125 | 154 | 174 | 220 | 262 | 206 | 215 |
| Total Liabilities | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 | 1,142 | 1,079 | 1,131 |
| Fixed Assets | 11 | 12 | 26 | 31 | 130 | 256 | 478 | 509 | 610 | 630 | 644 | 683 |
| CWIP | 1 | 0 | 0 | 0 | 66 | 129 | 46 | 110 | 70 | 86 | 66 | 21 |
| Investments | 2 | 2 | 7 | 7 | 20 | 34 | 42 | 53 | 53 | 54 | 54 | 64 |
| Other Assets | 26 | 26 | 35 | 58 | 187 | 210 | 240 | 410 | 373 | 371 | 315 | 364 |
| Total Assets | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 | 1,142 | 1,079 | 1,131 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 6 | 18 | 9 | 18 | 77 | 160 | 115 | -11 | 183 | 85 | 59 | 44 |
| Investing | -1 | -1 | -1 | -6 | -88 | -191 | -135 | -120 | -91 | -65 | -27 | -39 |
| Financing | -5 | -16 | -4 | -5 | 2 | 35 | 22 | 146 | -109 | -23 | -28 | -11 |
| Net Cash Flow | 0 | 0 | 4 | 7 | -8 | 5 | 1 | 14 | -17 | -3 | 4 | -6 |
| Free Cash Flow | 5 | 16 | 5 | 11 | -6 | -42 | -37 | -126 | 96 | 20 | 29 | 11 |
| CFO/OP | 89 | 150 | 87 | 97 | 69 | 115 | 94 | 10 | 154 | 218 | 109 | 47 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 71 | 88 | 112 | 73 | 69 | 74 | 97 | 85 | 113 | 88 | 120 |
| Inventory Days | 42 | 36 | 97 | 44 | 45 | 47 | 85 | 58 | 69 | 104 | 71 | 76 |
| Days Payable | 7 | 50 | 130 | 154 | 80 | 97 | 135 | 76 | 100 | 189 | 117 | 102 |
| Cash Conversion Cycle | 110 | 57 | 55 | 2 | 37 | 20 | 25 | 80 | 54 | 28 | 43 | 95 |
| Working Capital Days | 53 | 59 | 69 | 41 | 51 | 21 | 4 | 9 | 4 | -7 | -16 | 18 |
| ROCE % | 43% | 61% | 52% | 48% | 91% | 41% | 27% | 18% | 12% | 1% | 3% | 6% |
Documents
1
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Apr - Newspaper publication regarding Second 100 days Campaign-"Saksham Niveshak" 9 Apr - Newspaper publication regarding Second 100 days Campaign-"Saksham Niveshak"
2
Intimation Regarding Second 100-Days Campaign - ''''Saksham Niveshak''''
6 Apr - Valiant Organics launches IEPFA 'Saksham Niveshak' campaign from Apr 1-Jul 9, 2026 for unpaid dividends and KYC updates. 6 Apr - Valiant Organics launches IEPFA 'Saksham Niveshak' campaign from Apr 1-Jul 9, 2026 for unpaid dividends and KYC updates.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - RTA confirms Regulation 74(5) compliance for quarter and year ended March 31, 2026. 4 Apr - RTA confirms Regulation 74(5) compliance for quarter and year ended March 31, 2026.
4
Closure of Trading Window
26 Mar - Trading window closed from April 1, 2026 until 48 hours after results for quarter/year ended March 31, 2026. 26 Mar - Trading window closed from April 1, 2026 until 48 hours after results for quarter/year ended March 31, 2026.
5
Clarification On Price Movement Of The Security Of The Company.
24 Mar - Valiant Organics clarifies March 24, 2026 price movement; no undisclosed price-sensitive information, market-driven. 24 Mar - Valiant Organics clarifies March 24, 2026 price movement; no undisclosed price-sensitive information, market-driven.
Frequently Asked Questions about Valiant Organics Ltd
What does Valiant Organics Ltd do?
Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]
Where is Valiant Organics Ltd (VALIANTORG) listed?
Valiant Organics Ltd is listed on the Indian stock exchanges. It is listed on NSE: VALIANTORG and BSE: 540145. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Valiant Organics Ltd belong to?
Valiant Organics Ltd operates in the Commodities sector within the Chemicals & Petrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Valiant Organics Ltd?
Valiant Organics Ltd has a market capitalisation of approximately ₹847.48 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Valiant Organics Ltd?
The Price-to-Earnings (PE) ratio of Valiant Organics Ltd is 16.89. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Valiant Organics Ltd?
Over the past 52 weeks, Valiant Organics Ltd has traded between a low of ₹195 and a high of ₹397. This range helps investors understand the stock's price volatility and recent trading levels.
Does Valiant Organics Ltd pay dividends?
Yes, Valiant Organics Ltd has a dividend yield of 0.33%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Valiant Organics Ltd?
Valiant Organics Ltd has a Return on Equity (ROE) of -0.47%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Valiant Organics Ltd on Tapetide?
On Tapetide, you can view Valiant Organics Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1984, Valiant Organics Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]
Website valiantorganics.com
CEO Mr. Sathiababu Krishnan Kallada
Employees 942
Listed 2021-07-23
Face Value ₹ 10
Issued Size 2,76,14,049